002020 京新藥業
按盤價 
20.900 +1.530 (+7.899%)
20.900 +1.530 (+7.899%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.907 | 12.401 | 11.613 | 13.235 | 13.954 |
| 總資產報酬率 ROA (%) | 6.995 | 8.648 | 8.064 | 9.522 | 10.031 |
| 投入資產回報率 ROIC (%) | 8.851 | 10.975 | 10.130 | 11.708 | 12.392 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.070 | 49.974 | 50.573 | 53.275 | 55.470 |
| 營業利潤率 (%) | 21.792 | 20.286 | 17.857 | 20.017 | 20.137 |
| 息稅前利潤/營業總收入 (%) | 20.632 | 18.746 | 16.360 | 17.937 | 19.095 |
| 淨利潤/營業總收入 (%) | 19.074 | 17.293 | 15.590 | 17.668 | 17.826 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.812 | 93.439 | 89.232 | 92.627 | 89.350 |
| 價值變動淨收益/利潤總額(%) | 2.520 | -3.959 | 6.103 | 5.780 | 7.918 |
| 營業外收支淨額/利潤總額(%) | 0.099 | 0.044 | -0.850 | -0.840 | 0.212 | 償債能力分析 |
| 流動比率 (X) | 1.620 | 1.361 | 1.616 | 1.807 | 2.316 |
| 速動比率 (X) | 1.216 | 0.989 | 1.302 | 1.381 | 1.839 |
| 資產負債率 (%) | 28.741 | 29.221 | 30.631 | 29.753 | 25.169 |
| 帶息債務/全部投入資本 (%) | 5.015 | 5.566 | 6.452 | 6.879 | 5.501 |
| 股東權益/帶息債務 (%) | 1,782.583 | 1,604.489 | 1,358.410 | 1,261.677 | 1,641.567 |
| 股東權益/負債合計 (%) | 246.448 | 240.923 | 225.326 | 234.920 | 295.028 |
| 利息保障倍數 (X) | -17.468 | -12.098 | -12.154 | -9.375 | -17.614 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 71.267 | 57.105 | 47.079 | 44.518 | 41.288 |
| 存貨周轉天數 (天) | 139.831 | 125.062 | 129.902 | 147.920 | 137.414 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
